Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emergen-C is a leading consumer healthcare brand that specializes in the development and manufacture of effervescent dietary supplements, primarily focused on vitamin C delivery. Originally founded by Alacer Corp in 1972, the brand is widely recognized for its powdered drink mixes intended to support immune health, enhance energy, and provide electrolyte replacement. The product portfolio has expanded significantly over the decades to include various delivery formats such as gummies, chewables, and crystals, targeting diverse wellness needs including sleep and hydration. In 2012, the brand was acquired by Pfizer, subsequently becoming part of a joint venture with GSK before being spun off into Haleon in 2022. Today, Emergen-C remains a dominant player in the global vitamin and supplement market, distributed extensively through retail and pharmacy channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emergen-C.